Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.31 -0.02 (0.86%)
Previous Close $2.33    52 Week High $4.76 
Open $2.36    52 Week Low $1.46 
Day High $2.39    P/E N/A 
Day Low $2.30    EPS $-1.91 
Volume 742,394       

(NASDAQ: LEGN) Delayed: 18.64 -0.55 (2.87%)
Previous Close $19.19    52 Week High
Open $19.48    52 Week Low
Day High $19.85    P/E N/A 
Day Low $18.61    EPS
Volume 4,279,421